372 related articles for article (PubMed ID: 23419793)
1. Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles.
Tal R; Seifer DB; Khanimov M; Schwartz E; Grazi RV; Malter HE
Reprod Biomed Online; 2013 Apr; 26(4):360-7. PubMed ID: 23419793
[TBL] [Abstract][Full Text] [Related]
2. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
Tal R; Seifer DB; Wantman E; Baker V; Tal O
Fertil Steril; 2018 Feb; 109(2):258-265. PubMed ID: 29331235
[TBL] [Abstract][Full Text] [Related]
3. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
4. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.
Weghofer A; Dietrich W; Barad DH; Gleicher N
Hum Reprod; 2011 Jul; 26(7):1905-9. PubMed ID: 21531994
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
Seifer DB; Tal O; Wantman E; Edul P; Baker VL
Fertil Steril; 2016 Feb; 105(2):385-93.e3. PubMed ID: 26515380
[TBL] [Abstract][Full Text] [Related]
6. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone as a predictor of pregnancy following IVF.
Bhide P; Gudi A; Shah A; Timms P; Grayson K; Homburg R
Reprod Biomed Online; 2013 Mar; 26(3):247-52. PubMed ID: 23352101
[TBL] [Abstract][Full Text] [Related]
8. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.
Wang JG; Douglas NC; Nakhuda GS; Choi JM; Park SJ; Thornton MH; Guarnaccia MM; Sauer MV
Reprod Biomed Online; 2010 Dec; 21(6):757-61. PubMed ID: 21044868
[TBL] [Abstract][Full Text] [Related]
9. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.
Riggs R; Kimble T; Oehninger S; Bocca S; Zhao Y; Leader B; Stadtmauer L
Fertil Steril; 2011 Jan; 95(1):410-2. PubMed ID: 20736131
[TBL] [Abstract][Full Text] [Related]
11. AMH concentration is not related to effective time to pregnancy in women who conceive naturally.
Streuli I; de Mouzon J; Paccolat C; Chapron C; Petignat P; Irion OP; de Ziegler D
Reprod Biomed Online; 2014 Feb; 28(2):216-24. PubMed ID: 24365018
[TBL] [Abstract][Full Text] [Related]
12. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
[TBL] [Abstract][Full Text] [Related]
13. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
14. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.
Yates AP; Rustamov O; Roberts SA; Lim HY; Pemberton PW; Smith A; Nardo LG
Hum Reprod; 2011 Sep; 26(9):2353-62. PubMed ID: 21672928
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve and anti-Mullerian hormone (AMH) in mothers of dizygotic twins.
Van der Stroom EM; König TE; Vink JM; Boomsma DI; Lambalk CB
Twin Res Hum Genet; 2013 Apr; 16(2):634-8. PubMed ID: 23433063
[TBL] [Abstract][Full Text] [Related]
16. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone concentration as a biomarker of pregnancy success or failure.
Szafarowska M; Molinska-Glura M; Jerzak MM
Neuro Endocrinol Lett; 2014; 35(4):322-6. PubMed ID: 25038595
[TBL] [Abstract][Full Text] [Related]
18. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
[TBL] [Abstract][Full Text] [Related]
19. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
Fridén B; Sjöblom P; Menezes J
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118
[TBL] [Abstract][Full Text] [Related]
20. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
Niu ZH; Feng Y; Zhang AJ; Zhang HQ; Sun YJ; Lu XW
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]